N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide
TL;DR: N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide (CAS 533869-38-4) is a chemical compound with molecular formula C22H23ClN4O4S and molecular weight 474.11 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-(2-ethylpiperidin-1-yl)sulfonylbenzamide
Also Known As: N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide, N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-(2-ethylpiperidin-1-yl)sulfonylbenzamide, N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-[(2-ethylpiperidin-1-yl)sulfonyl]benzamide, N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-(2-ethylpiperidin-1-yl)sulfonyl-benzamide, N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-(2-ethylpiperidino)sulfonyl-benzamide
| Molecular Formula | C22H23ClN4O4S |
|---|---|
| Molecular Weight | 474.11 g/mol |
| LogP | 4.5955 |
| Topological Polar Surface Area | 105.4 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Exact Mass | 474.11285 |
| Heavy Atoms | 32 |
| Complexity | 1210.6786 |
Chemical Identifiers
| CAS Number | 533869-38-4 |
|---|---|
| SMILES | CCC1CCCCN1S(=O)(=O)C2=CC=C(C=C2)C(=O)NC3=NN=C(O3)C4=CC=CC=C4Cl |
Product Overview
N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide (CAS 533869-38-4), with molecular formula C22H23ClN4O4S and molecular weight 474.11 g/mol. IUPAC: N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-4-(2-ethylpiperidin-1-yl)sulfonylbenzamide.
Chemical Property Profile of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide
Property Insights of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide
The XLogP value of 4.5955 indicates that N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 105.4 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide. Following Lipinski's Rule of Five, N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide?
The CAS number of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide is 533869-38-4.
What is the molecular formula of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide?
The molecular formula of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide is C22H23ClN4O4S.
What is the molecular weight of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide?
The molecular weight of N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide is 474.11 g/mol.
Where can I buy N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide?
You can request a quote for N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide?
Yes, KEHONG BIO provides custom synthesis services for N-(5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl)-4-((2-ethylpiperidin-1-yl)sulfonyl)benzamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.